Suvi Parviainen

Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

Iulia Diaconu, Vincenzo Cerullo, Mari Hirvinen et al. · Cancer Research · 2012 · 162 citations · Full text

Medicine, Immunology, Oncology +17

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

Otto Hemminki, Suvi Parviainen, Juuso Juhila et al. · Oncotarget · 2015 · 87 citations · Full text

Life Sciences, Immunology, Oncology +12

Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus

Mari Hirvinen, Maria Rajecki, Mika Kapanen et al. · Human Gene Therapy · 2015 · 58 citations

Life Sciences, Immunology, Oncology +16

Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma

Mikko Siurala, Simona Bramante, Lotta Vassilev et al. · International Journal of Cancer · 2014 · 54 citations · Full text

Medicine, Oncology, Pharmacology +13

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

Mikko Siurala, Riikka Havunen, Dipongkor Saha et al. · Molecular Therapy · 2016 · 51 citations · Full text

Medicine, Immunology, Oncology +17